Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis-Reference-Cited by-同舟云学术

Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis

Published:2021-09-15 Issue:18 Volume:60 Page:2967-2971
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Oda Naohiro¹,Tabata Masahiro²,Uno Masatoshi³,Umeda Yuzo⁴,Kato Hironari⁵,Kubo Toshio²,Senoo Satoru¹,Yagi Takahito⁴,Fujiwara Toshiyoshi⁶,Maeda Yoshinobu⁷,Kiura Katsuyuki¹

Affiliation:

1. Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan

2. Center for Clinical Oncology, Okayama University Hospital, Japan

3. Department of Internal Medicine, Kaneda Hospital, Japan

4. Department of Hepato-Biliary-Pancreatic Surgery, Okayama University Hospital, Japan

5. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan

6. Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan

7. Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/18/60_6730-20/_pdf

Reference12 articles.

1. 1. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 23: 410-422, 1999.

2. 2. Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17: 738-753, 2017.

3. 3. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67: 789-804, 2018.

4. 4. Brunetti O, Aprile G, Marchetti P, et al. Systemic chemotherapy for advanced rare pancreatic histotype tumors: a retrospective multicenter analysis. Pancreas 47: 759-771, 2018.

5. 5. Doulamis IP, Mylonas KS, Kalfountzos CE, Mou D, Haj-Ibrahim H, Nasioudis D. Pancreatic mucinous cystadenocarcinoma: epidemiology and outcomes. Int J Surg 35: 76-82, 2016.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens;Therapeutic Advances in Medical Oncology;2023-01

2. Antineoplastics;Reactions Weekly;2021-05